🇺🇸 FDA
Patent

US 11007254

Compositions and methods for treating central nervous system injury

granted A61KA61K2039/505A61K38/1709

Quick answer

US patent 11007254 (Compositions and methods for treating central nervous system injury) held by United States Government as represented by the Department of Veterans Affairs expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K38/1709, A61K38/1725, A61K38/49